Stem cell clinics in Mexico publish their prices, which makes this one of the few corners of cross-border medicine where you can comparison shop before you commit. It also makes the spread visible: the same phrase, “stem cell therapy,” sits on a $2,160 joint injection and a $18,499 systemic protocol on price lists dated the same month.

This page reports what Mexican clinics charge as of September 2026 and what moves the number. It does not evaluate whether any of these treatments work, and nothing here is medical advice. Because the regulatory status of what is being sold is also the biggest single reason the price differs from the US price, this guide covers that too.

What Does Stem Cell Therapy in Mexico Cost?

Service/TypeLowTypicalHigh
Stem cell therapy, Mexico (national band)$1,700n/a$9,500
Mesenchymal cells, Wharton’s jelly or umbilical tissue$3,000n/a$4,600
Umbilical cord protocols$4,500n/a$8,000
Knee or joint protocol$3,700n/a$5,800
Joint package, Cancun clinic (10 million cells)n/a$3,000n/a
Autologous protocol using your own tissue, Cancun$8,200n/a$23,000
Stem cell therapy, Cancun (city band)$7,200n/a$18,500
Stem cell therapy, Guadalajara (one listed clinic)$1,655$5,578$9,500
Autoimmune and metabolic protocols, Tijuana clinic$6,218n/a$7,475
Neurological protocols, Tijuana clinic$8,664n/a$9,775
Knee or shoulder, Tijuana clinic$2,185n/a$8,223
Exosome protocols, Tijuana clinic$2,906n/a$7,506
Published cell-count ladder, 25M to 250M cells$3,999$9,499$18,499
Exosome-only, 100 to 200 billion$4,999n/a$7,999
US comparison figure used by medical-travel platformsn/a$13,900n/a

Sources disagree on the headline band, and that is worth understanding rather than averaging away. Bookimed’s Mexico page puts the typical range at $1,700 to $9,500 against a $13,900 US comparison, while its Cancun page puts that city at $7,200 to $18,500 and simultaneously lists Cancun packages at $3,000 and $4,500. ProgenCell in Tijuana states the Mexican range as $1,500 to $10,000.

Aggregator city averages deserve particular caution. Bookimed’s Guadalajara page reports an average of $5,578 with a $1,655 minimum and a $9,500 maximum, then lists exactly one clinic in the city. That is a national statistic wearing a city label. Use named clinic quotes instead.

What the cell count actually buys

The most transparent published structure in this market is a price-per-cell ladder. R3 Stem Cell’s Mexico list, marked effective July 2026, runs $3,999 for 25 million cells, $5,499 for 50 million, $9,499 for 100 million, $15,499 for 200 million and $18,499 for 250 million, with exosome vials, PRP and a multivitamin IV drip included at the higher tiers and two to three hotel nights bundled from 100 million cells up. Exosome-only treatment is listed at $4,999 for 100 billion and $7,999 for 200 billion, and card payments carry a 3% surcharge.

Read those lists carefully, because they are not always internally consistent. The same R3 page states in body text that 200 million cells “runs $7,999” while its own table prices 200 million at $15,499, and describes exosome-only therapy with 100 billion exosomes as $9,499 while the table says $4,999. Make the clinic confirm the figure in writing before you send a deposit.

Bookimed puts the same relationship in percentage terms: moving from 25 million to 200 million cells adds 50% to 65% to the cost.

Pricing by condition, not by session

ProgenCell, a Tijuana clinic five minutes from the San Ysidro crossing, publishes a condition-by-condition table instead. Rheumatoid arthritis, Sjogren’s, diabetes, chronic kidney disease, pulmonary fibrosis and asthma protocols are all listed at $6,218 to $7,475. Multiple sclerosis, autism, neuropathy, Parkinson’s and dementia protocols are listed at $8,664 to $9,775. Knee and shoulder work runs $2,185 to $8,223, exosomes $2,906 to $7,506, anti-aging protocols $3,565 to $6,452 and an NAD+ infusion $340. The same page puts its US comparison figures at $25,000 to $40,000 for the neurological categories and $10,000 to $15,000 for a knee or shoulder.

Bookimed’s platform-level condition prices start lower and climb higher: multiple sclerosis, autism and Parkinson’s from $5,000, cerebral palsy from $3,500, liver cirrhosis from $15,000 and muscular dystrophy from $20,000. Those are entry prices for a protocol, not a finished quote.

What Drives the Price

Cell count and cell source. This is the biggest lever and the one to interrogate first. Donor cells from umbilical cord tissue or Wharton’s jelly price differently from cells harvested from your own bone marrow or fat, and Bookimed’s Cancun page puts autologous protocols using your own tissue at $8,200 to $23,000 against $4,500 to $12,000 for umbilical cord-derived treatments. Ask what the product is, where it came from, and who counted the cells.

Whether it is one injection or a program. A single ultrasound-guided joint injection and a multi-day systemic protocol with labs, imaging, IV infusions and follow-up are different purchases marketed with the same words. A Cancun clinic lists a 10 million cell joint package at $3,000; a Playa del Carmen clinic lists a two-day package covering 50 million cells plus exosomes, placental protein and NAD+ at $2,160. Convert every quote to a per-session, per-region number before comparing.

Add-ons and travel that may or may not be inside the number. Exosomes, PRP, NAD+ and vitamin IVs appear as included extras on some ladders and as separate line items elsewhere, and several packages bundle airport transfers plus three days in a 4-star hotel only above a certain cell count. A cheaper number that excludes the hotel is not cheaper.

City. Tijuana and the border are the volume market for US patients because they are drivable. Cancun and the Riviera Maya price higher at the city level, at $7,200 to $18,500, while carrying individual packages at $3,000 to $4,500. Monterrey clinics list $2,500 for a localized application, $3,500 for an ultrasound-guided joint injection with 50 million cells and exosomes, and $7,100 for a premium program.

The Regulatory Picture

This is the part most price roundups skip, and it explains more of the price gap than overhead does.

In the United States. FDA states that the only stem cell products approved for use in the United States are blood-forming stem cells derived from umbilical cord blood, approved for disorders of the blood-forming system and not for other uses, and that there are currently no FDA-approved exosome products. FDA lists specifically that these products have not been approved for any orthopedic condition, including osteoarthritis, tendonitis, disc disease or knee, back, hip and shoulder pain, nor for any neurological disorder including multiple sclerosis, ALS, Alzheimer’s or Parkinson’s, nor for cardiovascular or pulmonary disease, nor for autism, blindness, chronic pain or fatigue. Compare that list against the marketing on any clinic page you are reading.

FDA is also direct with consumers: if you are being charged for these products outside a clinical trial with FDA oversight, you are likely being offered a product illegally, and a listing on clinicaltrials.gov or a firm’s registration with FDA does not mean a product is legally marketed. FDA has received reports of blindness, tumor formation, life-threatening bloodstream infections and unwanted immune reactions tied to unapproved regenerative products. Our US stem cell therapy cost guide covers the domestic market and current enforcement.

In Mexico. COFEPRIS, the federal commission for protection against sanitary risk, is the regulator, and clinics selling to US patients advertise COFEPRIS permits and COFEPRIS-authorized laboratories as their main credential. That permit is worth asking about specifically, because it is not a blanket endorsement of a therapy. In Comunicado 114, dated December 27, 2015, COFEPRIS suspended the cell therapy area of a Mexico City center for operating without authorized scientific research protocols or human clinical studies supporting the mesenchymal cell treatments it was selling, and for not guaranteeing flow cytometry to verify cell count and viability. In that release COFEPRIS stated plainly that stem cell treatments lack authorization because their efficacy is not proven, and told patients to be careful with anyone offering these services.

Flow cytometry is the useful takeaway. Ask whether anyone measures what is actually in the vial, and ask for the certificate of analysis.

Cash Price vs. Insurance

There is no insurance side to this market on either side of the border, and the reason is regulatory rather than actuarial. Because these products are not approved for the conditions being marketed, there is no billing code, no allowed amount and no network rate. US plans do not cover the therapy at home, so there is nothing to extend abroad.

The consequences cut both ways. There is no surprise balance bill, because the posted price is the whole price. There is also no insurer negotiating on your behalf, so the number you accept is entirely a function of how well you shop. Run any quote through our fair price checker against the figures on this page.

HSA and FSA cards sometimes clear these charges depending on the administrator, which is worth confirming before you pay. If you are weighing cross-border treatment generally, our medical tourism in Mexico guide covers the travel, records and follow-up logistics that apply to any procedure abroad.

How to Pay Less

Price the cheaper rungs of the ladder first. For joint pain specifically, a PRP injection or a gel injection costs a fraction of a stem cell protocol and both have published US prices you can check without leaving the country.

Convert every quote to the same unit. Sessions, regions, cell count, and what is bundled. A $3,000 single-joint package and a $9,499 systemic protocol are not competing offers until you have done that math.

Ask what is free at your tier, and get the price in writing. Published ladders include exosome vials, PRP and hotel nights above certain cell counts, so ask what crossing a threshold adds. And read the page for contradictions: at least one major published price list disagrees with itself between its table and its body text. A written quote resolves that; a phone number does not.

Negotiate, and ask how payment method changes the price. These clinics price-match, run promotions and charge card surcharges. Our guide to negotiating medical bills applies to an elective quote as much as to a hospital statement.

Do not turn a wellness purchase into a credit problem. Cash-pay regenerative medicine debt is ordinary consumer debt, not medical debt, which changes how it is collected. See our guide to medical bills in collections. If cost is the barrier to basic evaluation of the underlying problem, a free or sliding-scale clinic can handle that for far less.

The Bottom Line

Budget $1,700 to $9,500 for a single stem cell treatment in Mexico as of September 2026, $3,999 to $18,499 buying by cell count, and $6,218 to $9,775 for the condition-based protocols one Tijuana clinic publishes. Cancun runs higher at the city level and lower at the package level, which tells you how little a city average is worth here.

Then settle two things before the deposit: exactly what product you are buying and who verified the cell count, and what the clinic’s COFEPRIS permit actually authorizes. FDA’s position on these products for the conditions they are marketed for is not ambiguous. Knowing it does not stop you from traveling, but you should be paying with your eyes open.

For other cash-pay regenerative services, see our guides to hyperbaric oxygen therapy and cord blood banking, and our mommy makeover in Mexico and tummy tuck in Mexico guides run the same cross-border arithmetic on surgical care.